Dataset | Cell type | Total cells |
---|---|---|
mIHC ovarian cancer | CD19+ | 15267 (5%) |
CD3+/CD8- | 15952 (5.3%) | |
CD3+/CD8+ | 41008 (13.6%) | |
CD68+ | 57632 (19.1%) | |
CK+/Ki67+ | 172288 (57%) | |
mIHC lung cancer | CD14+ | 175878 (11.1 %) |
CD19+ | 154045 (9.7 %) | |
CD4+ | 232878 (14.6 %) | |
CD8+ | 124102 (7.8 %) | |
CK+ | 594140 (37.4 %) | |
Other+ | 309284 (19.4 %) | |
MIBI breast cancer | Unidentified | 1839 (1 %) |
Immune | 83336 (41.3 %) | |
Endothelial | 2089 (1 %) | |
Mesenchymal-like | 8479 (4.2 %) | |
Tumor | 3177 (1.6 %) | |
Keratin-positive tumor | 102736 (50.9 %) |